Saturday, October 31, 2026

Bitcoin Cash USD On Bullish Momentum: 5.51% Up In The Last 6 Hours

ViaNews Editorial Team

December 28, 2020

Bitcoin Cash USD On Bullish Momentum: 5.51% Up In The Last 6 Hours

Bitcoin Cash USD is currently on bullish momentum. At 07:07 EST on Monday, 28 December, Bitcoin Cash USD is at $368.76 and up by 5.51% in the last 6 hours.

Bitcoin Cash USD Range

Over the last six hours, Bitcoin Cash USD's higher value was $368.76 and the lower value was $349.49.

Over the last twelve hours, Bitcoin Cash USD's higher value was $368.76 and the lower value was $344.08.

About Bitcoin Cash USD's daily lows, it's 14.657% up from its trailing 24-hour low of $321.62

Regarding Bitcoin Cash USD's yearly highs and lows, it's 164.876% up from its 52-week low and 25.205% down from its 52-week high.

Volatility

Bitcoin Cash USD's last day and last week average volatility is a positive 4.75% and a positive 7.96%, respectively. Bitcoin Cash USD's high and low amplitude percentage in the last week was 12.53%.

News about Bitcoin

Bitcoin surges to fresh record high and looks set to break the $25,000 level: 'merry bitmas'. According to Business Insider on Fri Dec 25, "Bitcoin has a current market cap of about $350 billion, while that of gold's stands at roughly $10 trillion.", "However, Bitcoin investors - known for their unquenchable optimism - think this is just the start."

Bitcoin miners in nordic region get a boost from cheap power. According to Bloomberg Quint on Sun Dec 27, ""There is a very important strategic shift away from mining in China to mining in western countries like Sweden as Bitcoin investors become more public and want more stability and critical safety," said Salter at Genesis. ", "The current market dynamics give big miners alternatives to places where Bitcoin are usually created such as China, Kazakhstan and Canada."

Bitcoin faces regulatory scrutiny after record-breaking rally. According to Bloomberg Quint on Sun Dec 27, "Janet Yellen, who's been nominated to serve as Treasury secretary in Biden's administration, has in recent years cautioned investors over Bitcoin, saying it was a "highly speculative asset" and "not a stable store of value." A representative didn't immediately return a request seeking comment.", ""What's happening now -- and it's happening faster than anyone could ever imagine -- is that Bitcoin is moving from a fringe esoteric asset to the mainstream," said Matt Hougan, chief investment officer of Bitwise Asset Management. "

Bitcoin on longest winning run since 2019 after hitting record. According to Bloomberg Quint on Mon Dec 28, "Ayyar said investors are shifting to Bitcoin and other digital coins in the wake of the XRP development.", "Bitcoin climbed as much as 3.6% on Monday and was trading at about $27,150 as of 1 p.m. in Tokyo. "

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com